Compared with a $4.56 million loss for the previous year.
Net revenues of $2.2 million and an EBITDA loss of $3.57 million were better than market forecasts.
- Forums
- ASX - By Stock
- GAA
- net loss 5.6m
GAA
genepharm australasia limited